IperionX Limited
TAOFF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 8.68 | 38.55 | 0.00 | 94.67 |
| FCF Yield | -2.33% | -1.62% | -0.00% | -2.40% |
| EV / EBITDA | 2,830.46 | -1,349.90 | -44,943.65 | -36,499.95 |
| Quality | ||||
| ROIC | -0.02% | -0.02% | 0.70% | -0.03% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.53 | 72.36 | 0.94 | 717.36 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 98.57% | -23,332.94% | 99.85% | -1,136.70% |
| Safety | ||||
| Net Debt / EBITDA | 2,886.95 | 3,617.44 | 5,104.24 | 3,120.21 |
| Interest Coverage | -7.57 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |